home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Kronos Bio Reports Recent Business Progress and Third-Quarter 2022 Financial Results
Kronos Bio Reports Recent Business Progress and Third-Quarter 2022 Financial Results
Post navigation
Previous Post
Previous
Arvinas Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Next Post
Next
Kronos Bio Announces Prioritization of Clinical Portfolio to Focus on Lanraplenib and KB-0742